74
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder

, , , , , & show all
Pages 135-143 | Received 21 Apr 2009, Accepted 25 May 2009, Published online: 01 Feb 2010

References

  • Zuddas A, Ancilletta B, Muglia P, Cianchetti C. Attention-deficit/ hyperactivity disorder: a neuropsychiatric disorder with childhood onset. Eur J Paediatr Neurol 2000; 4:53–62.
  • Faraone SV, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2003; 2:104–113.
  • Gau SS, Chong MY, Chen TH, Cheng AT. A 3-year panel study of mental disorders among adolescents in Taiwan. Am J Psychiatry 2005; 162:1344–1350.
  • Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991; 148:564–577.
  • Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry 2005; 57:1215–1220.
  • Biederman J, Petty CR, Dolan C . The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study. Psychol Med 2008; 38:1027–1036.
  • Biederman J, Faraone SV, Keenan K . Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 1992; 49:728–738.
  • Wozniak J, Biederman J, Kiely K . Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry 1995; 34:867–876.
  • Vance A, Harris K, Boots M, Talbot J, Karamitsios M. Which anxiety disorders may differentiate attention deficit hyperactivity disorder, combined type with dysthymic disorder from attention deficit hyperactivity disorder, combined type alone? Aust N Z J Psychiatry 2003; 37:563–569.
  • Bowen R, Chavira DA, Bailey K, Stein MT, Stein MB. Nature of anxiety comorbid with attention deficit hyperactivity disorder in children from a pediatric primary care setting. Psychiatry Res 2008; 157:201–209.
  • Vance A, Costin J, Barnett R, Luk E, Maruff P, Tonge B. Characteristics of parent- and child-reported anxiety in psychostimulant medication naive, clinically referred children with attention deficit hyperactivity disorder, combined type (ADHD-CT). Aust N Z J Psychiatry 2002; 36:234–239.
  • Pastor PN, Reuben CA. Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004–2006. Vital Health Stat 10 2008; 237:1–14.
  • Erenberg G. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review. Semin Pediatr Neurol 2005; 12:217–221.
  • Elkins IJ, McGue M, Iacono WG. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiatry 2007; 64:1145–1152.
  • Arias AJ, Gelernter J, Chan G . Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav 2008; 33:1199–1207.
  • Smalley SL, McGough JJ, Moilanen IK . Prevalence and psychiatric comorbidity of attention-deficit/hyperactivity disorder in an adolescent Finnish population. J Am Acad Child Adolesc Psychiatry 2007; 46:1575–1583.
  • Molina BS, Pelham WE Jr. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol 2003; 112:497–507.
  • Disney ER, Elkins IJ, McGue M, Iacono WG. Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence. Am J Psychiatry 1999; 156:1515–1521.
  • Kollins SH, McClernon FJ, Fuemmeler BF. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch Gen Psychiatry 2005; 62:1142–1147.
  • Burns GL, Walsh JA. The influence of ADHD-hyperactivity/impulsivity symptoms on the development of oppositional defiant disorder symptoms in a 2-year longitudinal study. J Abnorm Child Psychol 2002; 30:245–256.
  • Monuteaux MC, Faraone SV, Michelle Gross L, Biederman J. Predictors, clinical characteristics, and outcome of conduct disorder in girls with attention-deficit/hyperactivity disorder: a longitudinal study. Psychol Med 2007; 37:1731–1741.
  • Hurtig T, Ebeling H, Taanila A . ADHD symptoms and sub-types: relationship between childhood and adolescent symptoms. J Am Acad Child Adolesc Psychiatry 2007; 46:1605–1613.
  • Pollack MA, Cohen NL, Friedhoff AJ. Gilles de la Tourette's syndrome. Familial occurrence and precipitation by methylphenidate therapy. Arch Neurol 1977; 34:630–632.
  • Golden GS. Gilles de la Tourette's syndrome following methylphenidate administration. Dev Med Child Neurol 1974; 16:76–78.
  • Parraga HC, Parraga MI, Harris DK. Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder. Int J Psychiatry Med 2007; 37:415–424.
  • Connor DF, Edwards G, Fletcher KE, Baird J, Barkley RA, Steingard RJ. Correlates of comorbid psychopathology in children with ADHD. J Am Acad Child Adolesc Psychiatry 2003; 42:193–200.
  • Biederman J, Faraone SV, Keenan K, Steingard R, Tsuang MT. Familial association between attention deficit disorder and anxiety disorders. Am J Psychiatry 1991; 148:251–256.
  • Takahashi K, Miyawaki D, Suzuki F . Hyperactivity and comorbidity in Japanese children with attention-deficit/hyperactivity disorder. Psychiatry Clin Neurosci 2007; 61:255–262.
  • Yang P, Jong YJ, Hsu HY, Tsai JH. Psychiatric features and parenting stress profiles of subtypes of attention-deficit/hyperactivity disorder: results from a clinically referred Taiwanese sample. J Dev Behav Pediatr 2007; 28:369–375.
  • Gau SF, Soong WT. Psychiatric comorbidity of adolescents with sleep terrors or sleepwalking: a case-control study. Aust N Z J Psychiatry 1999; 33:734–739.
  • Gau SS, Chiang HL. Sleep problems and disorders among adolescents with persistent and subthreshold attention-deficit/hyperactivity disorders. Sleep 2009; 32:671–679.
  • Gau SS, Chong MY, Yang P, Yen CF, Liang KY, Cheng AT. Psychiatric and psychosocial predictors of substance use disorders among adolescents: longitudinal study. Br J Psychiatry 2007; 190:42–48.
  • Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry 1982; 39:879–883.
  • Gau SS, Soong WT, Chiu YN, Tsai WC. Psychometric properties of the Chinese version of the Conners’ Parent and Teacher Rating Scales-Revised: Short Form. J Atten Disord 2006; 9:648–659.
  • Angold A, Costello EJ, Erkanli A. Comorbidity. J Child Psychol Psychiatry 1999; 40:57–87.
  • Spencer T, Biederman J, Coffey B, Geller D, Faraone S, Wilens T. Tourette disorder and ADHD. Adv Neurol 2001; 85:57–77.
  • Biederman J, Faraone S, Milberger S . Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1996; 35:343–351.
  • August GJ, Realmuto GM, MacDonald AW, Nugent SM, Crosby R. Prevalence of ADHD and comorbid disorders among elementary school children screened for disruptive behavior. J Abnorm Child Psychol 1996; 24:571–595.
  • Hurtig T, Ebeling H, Taanila A . ADHD and comorbid disorders in relation to family environment and symptom severity. Eur Child Adolesc Psychiatry 2007; 16:362–369.
  • Whittinger NS, Langley K, Fowler TA, Thomas HV, Thapar A. Clinical precursors of adolescent conduct disorder in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007; 46:179–187.
  • Epstein JN, Conners CK, Hervey AS . Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry 2006; 47:446–456.
  • Kessler RC, Adler LA, Barkley R . Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry 2005; 57:1442–1451.
  • Vance AL, Maruff P, Barnett R. Attention deficit hyperactivity disorder, combined type: better executive function performance with longer-term psychostimulant medication. Aust N Z J Psychiatry 2003; 37:570–576.
  • Bauermeister JJ, Shrout PE, Chavez L . ADHD and gender: are risks and sequela of ADHD the same for boys and girls? J Child Psychol Psychiatry 2007; 48:831–839.
  • Levy F, Hay DA, Bennett KS, McStephen M. Gender differences in ADHD subtype comorbidity. J Am Acad Child Adolesc Psychiatry 2005; 44:368–376.
  • The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999; 56:1073–1086.
  • Kadesjo B, Gillberg C. The comorbidity of ADHD in the general population of Swedish school-age children. J Child Psychol Psychiatry 2001; 42:487–492.
  • Banaschewski T, Neale BM, Rothenberger A, Roessner V. Comorbidity of tic disorders and ADHD: conceptual and methodological considerations. Eur Child Adolesc Psychiatry 2007; 16 (Suppl 1):5–14.
  • Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 2002; 58:527–536.
  • Bird HR, Gould MS, Staghezza BM. Patterns of diagnostic comorbidity in a community sample of children aged 9 through 16 years. J Am Acad Child Adolesc Psychiatry 1993; 32:361–368.
  • Cohen P, Cohen J, Kasen S . An epidemiological study of disorders in late childhood and adolescence: I. Age- and gender-specific prevalence. J Child Psychol Psychiatry 1993; 34:851–867.
  • Geller D, Donnelly C, Lopez F . Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. J Am Acad Child Adolesc Psychiatry 2007; 46:1119–1127.
  • Gau SS, Shen HY, Soong WT, Gau CS. An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan. J Child Adolesc Psychopharmacol 2006; 16:441–455.
  • Wilens TE, Adamson J, Sgambati S . Do individuals with ADHD self-medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD. Am J Addict 2007; 16 (Suppl 1):14–21.
  • Biederman J, Monuteaux MC, Spencer T, Wilens TE, Macpherson HA, Faraone SV. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry 2008; 165:597–603.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.